In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

MediciNova completes $113.4mm IPO

Executive Summary

MediciNova (focused primarily on developing compounds for urological and gynecological conditions) has netted $113.4mm (Y11.9bn) with its initial public offering of 31.6mm shares (including the overallotment) priced at $3.88 each. The company, which exceeded its hopes of bringing in $100mm, sold shares to Japanese and other ex-US investors and is now listed on the Hercules Market of the Osaka Securities Exchange
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies